251 related articles for article (PubMed ID: 24499194)
1. Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus.
Bruckman MA; Jiang K; Simpson EJ; Randolph LN; Luyt LG; Yu X; Steinmetz NF
Nano Lett; 2014 Mar; 14(3):1551-8. PubMed ID: 24499194
[TBL] [Abstract][Full Text] [Related]
2. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
3. Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging.
Chan JMS; Monaco C; Wylezinska-Arridge M; Tremoleda JL; Cole JE; Goddard M; Cheung MSH; Bhakoo KK; Gibbs RGJ
J Vasc Surg; 2018 May; 67(5):1571-1583.e3. PubMed ID: 28648478
[TBL] [Abstract][Full Text] [Related]
4. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
[TBL] [Abstract][Full Text] [Related]
5. Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
Bala G; Blykers A; Xavier C; Descamps B; Broisat A; Ghezzi C; Fagret D; Van Camp G; Caveliers V; Vanhove C; Lahoutte T; Droogmans S; Cosyns B; Devoogdt N; Hernot S
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):1001-8. PubMed ID: 26800768
[TBL] [Abstract][Full Text] [Related]
6. In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.
Dimastromatteo J; Broisat A; Perret P; Ahmadi M; Boturyn D; Dumy P; Fagret D; Riou LM; Ghezzi C
J Nucl Med; 2013 Aug; 54(8):1442-9. PubMed ID: 23719858
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
[TBL] [Abstract][Full Text] [Related]
8. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
[TBL] [Abstract][Full Text] [Related]
9. Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.
Hu H; Zhang Y; Shukla S; Gu Y; Yu X; Steinmetz NF
ACS Nano; 2017 Sep; 11(9):9249-9258. PubMed ID: 28858475
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40.
Sun X; Li W; Zhang X; Qi M; Zhang Z; Zhang XE; Cui Z
Nano Lett; 2016 Oct; 16(10):6164-6171. PubMed ID: 27622963
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
[TBL] [Abstract][Full Text] [Related]
12. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
[TBL] [Abstract][Full Text] [Related]
13. S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE
Park J; Gao H; Wang Y; Hu H; Simon DI; Steinmetz NF
J Mater Chem B; 2019 Mar; 7(11):1842-1846. PubMed ID: 32255046
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
[TBL] [Abstract][Full Text] [Related]
15. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.
Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
[TBL] [Abstract][Full Text] [Related]
17. Nitroxyl Modified Tobacco Mosaic Virus as a Metal-Free High-Relaxivity MRI and EPR Active Superoxide Sensor.
Dharmarwardana M; Martins AF; Chen Z; Palacios PM; Nowak CM; Welch RP; Li S; Luzuriaga MA; Bleris L; Pierce BS; Sherry AD; Gassensmith JJ
Mol Pharm; 2018 Aug; 15(8):2973-2983. PubMed ID: 29771534
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
